Evaluation of inflammatory infiltrate and fibrogenic cytokines in pseudopelade of Brocq suggests the involvement of T-helper 2 and 3 cytokines

British Journal of Dermatology

Volumn 151, Issue 1, 2004, Pages 84-90

  Moretti, S ^a   Amato, L ^a   Massi, D ^a   Bianchi, B ^a   Gallerani, I ^a   Fabbri, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fibrogenic cytokines; Immunophenotype; Pseudopelade

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; FIBROGENESIS; HELPER CELL; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LANGERHANS CELL; MACROPHAGE; MAST CELL; MEDICAL ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ALOPECIA; CYTOKINES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; MIDDLE AGED; SCALP; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; TRANSFORMING GROWTH FACTOR BETA;

EID: 4043171967     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05976.x     Document Type: Article

References (25)

1. Brocq L, Lenglet P, Avrygnac I. Reserchers sur l'alopecie atrophiante, variétè pseudo-pelade. Ann Dermatol Syphiligr 1905; 6: 209-37.
2. Braun-Falco O, Imai S, Schmoeckel C et al. Pseudopelade of Brocq. Dermatologica 1986; 172: 18-23.
3. Sperling LC, Solomon AR, Whiting DA. A new look at scarring alopecia. Arch Dermatol 2000; 136: 235-42.
4. Rook AJ, Dawber RPR. Cicatricial alopecia. In: Diseases of the Hair and Scalp, (Rook AJ, Dawber RPR, eds) 2nd edn. Oxford: Blackwell Scientific, 1990: 301-2.
5. Pinkus H. Alopecia. Int J Dermatol 1980; 19: 245-53.
6. Braun-Falco O, Bergner T, Heilgemeir GP. The Brocq pseudopelade - a disease picture or disease entity. Hautarzt 1989; 40: 77-83.
7. Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol 2001; 19: 211-25.
8. Amato L, Mei S, Massi D et al. Cicatricial alopecia: a dermatopathologic and immunopathologic study of 33 patients (pseudopelade of Brocq is not a specific clinicopathologic entity). Int J Dermatol 2002; 41: 8-15.
9. Degos R, Rabut R, Duperrat B, Leclercq R. Pseudopeladic state; comments on one hundred cases of circumscribed cicatricial alopecia, apparent primary, of pseudopelade type. Ann Dermatol Syphiligr (Paris) 1954; 81: 5-26.
10. Anderson SG, Addison IE, Dixon HG. Antinuclear factor serum (homogeneous): an international collaborative study of the proposed research standard 66-233. Ann NY Acad Sci 1971; 177: 337-45.
11. Carbonara AO, Mancini G, Heremans JF. Immunochemical quantitation of antigens by single radioimmunodiffusion. Immunohistochemistry 1965; 2: 235-41.
12. Fabbri P, Panconesi E. Clinical-immunologic correlations in pemphigus and pemphigoid. Int J Dermatol 1979; 18: 569-70.
13. Moretti S, Pinzi C, Spallanzani A et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer (Pred Oncol) 1999; 84: 160-8.
14. Carli P, Moretti S, Spallanzani A et al. Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study. J Reprod Med 1997; 42: 161-5.
15. Moretti S, Pinzi C, Berti E et al. In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLADR and beta3 integrin expression. Melanoma Res 1997; 7: 313-21.
16. Alcover A, Alacorn B. Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol 2000; 20: 325-46.
17. Fabbri P, Acampa D, Zangheri M. Immunopathological investigations in pseudopelade. It Gen Rev Dermatol 1985; 22: 49-55.
18. Wilson CL, Burge SM, Dean D, Dawber RPR. Scarring alopecia in discoid lupus erythematosus. Br J Dermatol 1992; 126: 307-14.
19. Nayar M, Schomberg K, Dawber RPR, Millard PR. A clinico-pathological study of scarring alopecia. Br J Dermatol 1993; 128: 533-6.
20. Annessi G, Lombardo G, Gobello T, Puddu P. A clinicopathologic study of scarring alopecia due to lichen planus. Comparison with scarring alopecia in discoid lupus erythematosus and pseudopelade. Am J Dermatopathol 1999; 21: 324-31.
21. Amato L, Massi D, Berti S et al. Multiparametric approach is essential to define different clinico-pathologic entities within pseudopelade of Brocq. Br J Dermatol 2002; 146: 352-3.
22. Pincelli C, Girolomoni G, Benassi L. Pseudopelade of Brocq: an immunologically mediated disease? Dermatologica 1987; 176: 49-51.
23. Toro JR, Finlay D, Dou X et al. Detection of type 1 cytokines in discoid lupus erythematosus. Arch Dermatol 2000; 136: 1497-501.
24. Pierard-Franchimont C, Pierard GE. Massive lymphocyte-mediated apoptosis during the early stage of pseudopelade. Dermatologica 1986; 172: 254-7.
25. Eichmuller S, Van der Veen C, Moll I et al. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998; 46: 361-70.